ATE332888T1 - Sphingosinderivate und medizinische zubereitung - Google Patents

Sphingosinderivate und medizinische zubereitung

Info

Publication number
ATE332888T1
ATE332888T1 AT98941825T AT98941825T ATE332888T1 AT E332888 T1 ATE332888 T1 AT E332888T1 AT 98941825 T AT98941825 T AT 98941825T AT 98941825 T AT98941825 T AT 98941825T AT E332888 T1 ATE332888 T1 AT E332888T1
Authority
AT
Austria
Prior art keywords
sphingosine derivatives
medical preparation
different
sphingosine
same
Prior art date
Application number
AT98941825T
Other languages
English (en)
Inventor
Kazutoh Takesako
Toru Kurome
Naoyuki Awazu
Ikunoshin Kato
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Application granted granted Critical
Publication of ATE332888T1 publication Critical patent/ATE332888T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/12Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
AT98941825T 1997-09-11 1998-09-11 Sphingosinderivate und medizinische zubereitung ATE332888T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26796597 1997-09-11

Publications (1)

Publication Number Publication Date
ATE332888T1 true ATE332888T1 (de) 2006-08-15

Family

ID=17452059

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98941825T ATE332888T1 (de) 1997-09-11 1998-09-11 Sphingosinderivate und medizinische zubereitung

Country Status (8)

Country Link
US (1) US6239297B1 (de)
EP (1) EP1020429B1 (de)
JP (1) JP4091250B2 (de)
KR (1) KR100561890B1 (de)
AT (1) ATE332888T1 (de)
AU (1) AU9002298A (de)
DE (1) DE69835223T2 (de)
WO (1) WO1999012890A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1363643A2 (de) 2000-12-22 2003-11-26 Medlyte, Inc. Zusammensetzungen und methoden zur behandlung und vorbeugung von kardiovaskulären erkrankungen und zur identifizierung therapeutischer mittel
AU2002237988B2 (en) * 2001-01-30 2008-01-03 University Of Virginia Patent Foundation Agonists and antagonists of sphingosine-1-phosphate receptors
ITRM20010688A1 (it) * 2001-11-21 2003-05-21 Univ Roma Composti immunoregolatori.
US6838114B2 (en) * 2002-05-24 2005-01-04 Micron Technology, Inc. Methods for controlling gas pulsing in processes for depositing materials onto micro-device workpieces
NL1022443C2 (nl) * 2003-01-20 2004-07-22 Tno Sphingolipiden voor verbetering van de samenstelling van de darmflora.
DE102004025000A1 (de) * 2004-05-21 2005-12-08 Bayer Technology Services Gmbh Verfahren zur Herstellung von chemischen und pharmazeutischen Produkten mit integrierter Mehrsäulen-Chromatographie
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
GB0513431D0 (en) * 2005-06-30 2005-08-10 Kherion Technology Ltd Prophylactic compositions and uses
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
US8097644B2 (en) * 2006-03-28 2012-01-17 Allergan, Inc. Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
US9217749B2 (en) 2006-05-31 2015-12-22 Lpath, Inc. Immune-derived moieties reactive against lysophosphatidic acid
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US8796429B2 (en) 2006-05-31 2014-08-05 Lpath, Inc. Bioactive lipid derivatives, and methods of making and using same
RU2460541C2 (ru) 2006-10-27 2012-09-10 Лпат, Инк. Композиции и способы связывания сфингозин-1-фосфата
US8524917B2 (en) * 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
KR20090101307A (ko) 2007-01-11 2009-09-24 알러간, 인코포레이티드 스핑고신-1-포스페이트(s1p) 수용체 길항제 생물학적 활성을 갖는 6-치환된 인돌-3-카르복실산 아미드 화합물
US7888336B2 (en) * 2007-09-24 2011-02-15 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity
US8143291B2 (en) 2008-05-09 2012-03-27 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
RU2505527C2 (ru) * 2008-08-12 2014-01-27 Аллерган, Инк. Антагонисты рецептора сфингозин-1-фосфата (s1p) и способы их применения
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
KR20120028867A (ko) * 2009-04-02 2012-03-23 알러간, 인코포레이티드 프로스타글란딘 e 수용체 길항제
US20120088800A1 (en) 2009-06-30 2012-04-12 Allergan, Inc. 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS
US8168795B2 (en) 2009-08-11 2012-05-01 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
WO2011028927A1 (en) 2009-09-04 2011-03-10 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
AU2010300791A1 (en) 2009-09-29 2012-04-19 Allergan, Inc. Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors
US8741875B2 (en) 2009-11-24 2014-06-03 Allergan, Inc. Compounds as receptor modulators with therapeutic utility
MX2012006022A (es) 2009-11-24 2012-08-15 Allergan Inc Compuestos novedosos como moduladores de receptor con utilidad terapeutica.
BR112013012719A2 (pt) 2010-11-22 2019-09-24 Allergan Inc "compostos como moduladores de receptor com utilidade terapêutica".
AU2012316085A1 (en) * 2011-09-29 2014-05-22 Emory University Sphingosine analogs, compositions, and methods related thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02215711A (ja) * 1989-02-03 1990-08-28 Biomembrane Inst プロテインキナーゼ阻害剤としての、n‐メチル‐スフィンゴシン誘導体及びその立体異性体
JP2560250B2 (ja) * 1994-03-18 1996-12-04 工業技術院長 天然型スフィンゴシン類の製造方法とその合成中間体
KR100487703B1 (ko) * 1996-03-12 2005-06-16 다카라 바이오 가부시키가이샤 생리활성물질tkr1785류,제조방법및미생물

Also Published As

Publication number Publication date
AU9002298A (en) 1999-03-29
KR100561890B1 (ko) 2006-03-16
EP1020429A1 (de) 2000-07-19
WO1999012890A1 (fr) 1999-03-18
EP1020429B1 (de) 2006-07-12
JP4091250B2 (ja) 2008-05-28
DE69835223D1 (de) 2006-08-24
EP1020429A4 (de) 2004-09-08
DE69835223T2 (de) 2007-05-31
KR20010023477A (ko) 2001-03-26
US6239297B1 (en) 2001-05-29

Similar Documents

Publication Publication Date Title
DE69835223D1 (de) Sphingosinderivate und medizinische zubereitung
TR199701040T1 (xx) Yeni taksoidler ve bunlar�n haz�rlanmas�.
FR11C0038I2 (fr) Analogues macrocycliques, leurs procedes d'utilisation et de preparation
DE69604714T2 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
KR940021059A (ko) 지질 대사 개선제
ES2107284T3 (es) Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
KR960006915A (ko) 췌장염의 치료 조성물
PT916651E (pt) DERIVADOS DE áCIDO FENILALQUILCARBOXILICO
ATE229968T1 (de) Diagnostisches mittel zur glykostoffwechselfunktion
DE69001495D1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
TR199902350T2 (xx) Yeni piridin t�revleri ve onlardan olu�an farmakotik bile�imler.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
DE69118064T2 (de) Diamino-s-Triazinonderivate und diese enthaltende selbstlöschende polymere Zusammensetzungen
ES2046641T3 (es) Composicion antitumoral.
NO904187L (no) Benzanilider.
DE69602886D1 (de) Im kardiovaskulären System aktive seco-D-Steroide und diese enthaltende pharmazeutische Zubereitungen
SE8303913D0 (sv) Heterocykliska foreningar
ES2071786T3 (es) Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso.
ES2159843T3 (es) Derivados de 5,11-dihidrodibenzo(b,e)(1,4)oxazepina y composiciones medicamentosas que los contienen.
EP1061070A4 (de) 24-hydroxy-vitamin-d-derivate
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
DE69600714D1 (de) Antiallergische Zusammensetzung enthaltend eine Phosphorsäurediester-Verbindung
IL117497A0 (en) 17-Difluoromethylene estratriene derivatives and pharmaceutical compositions containing the same
ATE176242T1 (de) Uck14-verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties